Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 4Head and Neck Neoplasms 4Glioblastoma 4Breast Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Glioma 3Brain Neoplasms 3Virus Diseases 2Urinary Bladder Neoplasms 2Stomach Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors 2Nervous System Diseases 2Neoplasms, Neuroepithelial 2Neoplasms, Nerve Tissue 2Neoplasms 2Melanoma 2Liver Neoplasms 2Gliosarcoma 2Colorectal Neoplasms 2Carcinoma 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Pharyngeal Neoplasms 1Otorhinolaryngologic Neoplasms 1Nose Neoplasms 1Neoplasms, Glandular and Epithelial 1Neoplasms, Germ Cell and Embryonal 1Neoplasms by Histologic Type 1

Interventions

Leucovorin 2Irinotecan 2Fluorouracil 2Cetuximab 2spartalizumab 1pembrolizumab 1camrelizumab 1Radiosurgery 1Oxaliplatin 1Oncolytic Virotherapy 1KD025 1IFL protocol 1HLX07 1Folfox protocol 1Drug Therapy 1CCT239065 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × CRC × Oncolytic Virotherapy × Clear all
NCT07381309 2026-04-28

VVSHIP

Sixth Affiliated Hospital, Sun Yat-sen University

Phase 2 Not yet recruiting
114 enrolled
Gastrointestinal

CRC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡